Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × ibrutinib × Clear all

NCT03121534 2023-02-17

Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation

Phase 2 Terminated

9 enrolled 10 charts

Other hematologic neoplasm

Hematologic Neoplasms